Safety and immunogenicity of ChAdOx1 MERS Vaccine Candidate in Healthy Middle Eastern Adults: a dose-escalation, open-label, non-randomised, phase 1b trial by Bosaeed, M, Balkhy, HH, Almaziad, S, Folegatti, P, Bittaye, M, Aboagye, J, Ramos Lopez, F, Ewer, K, Gilbert, S

Deep immune phenotyping and single-cell transcriptomics allow identification of circulating TRM-like cells which correlate with liver-stage immunity and vaccine-induced protection... by Noe, A, Datoo, M, Flaxman, A, Jenkin, D, Bellamy, D, Makinson, R, Morter, R, Ramos Lopez, F, Sheridan, J, Voukantsis, D, Prasad, N, Hill, A, Ewer, K, Spencer, A

Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies by Folegatti, P, Flaxman, A, Jenkin, D, Makinson, R, Kingham, L, Bellamy, D, Ramos Lopez, F, Sheridan, J, Poulton, I, Aboagye, J, Tran, N, Mitton, C, Roberts, R, Lawrie, A, Hill, A, Ewer, KJ, Gilbert, S

A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults by Hanboonkunupakarn, B, Mukaka, M, Jittamala, P, Poovorawan, K, Pongsuwan, P, Stockdale, L, Provstgaard-Morys, S, Chotivanich, K, Tarning, J, Hoglund, RM, Chimjinda, N, Ewer, K, Ramos-Lopez, F, Day, NPJ, Dondorp, AM, Hill, AV, White, NJ, von Seidlein, L, Pukrittayakamee, S

A single dose of ChAdOx1 Chik vaccine induces neutralising antibodies against four chikungunya virus lineages in a phase 1 clinical trial by Folegatti, P, Harrison, K, Preciado-Llanes, L, Ramos Lopez, F, Bittaye, M, Kim, Y, Flaxman, A, Bellamy, D, Makinson, R, Sheridan, J, Tilley, M, Tran, N, Jenkin, D, Poulton, I, Lawrie, A, Roberts, R, Berrie, E, Hill, A, Ewer, K, Reyes-Sandoval, A

Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 t... by Folegatti, PM, Bittaye, M, Flaxman, A, Ramos Lopez, F, Bellamy, D, Mair, C, Makinson, R, Sheridan, J, Boyd, A, Tran, N, Silman, D, Poulton, I, Datoo, M, Marshall, J, Themistocleous, Y, Lawrie, A, Roberts, R, Berrie, E, Lambe, T, Hill, A, Ewer, K, Gilbert, S, Et al.

Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: safety and parasite growth dynamics by Salkeld, J, Themistocleous, Y, Barrett, JR, Mitton, CH, Rawlinson, TA, Payne, RO, Hou, MM, Khozoee, B, Edwards, NJ, Nielsen, CM, Sandoval, DM, Bach, FA, Nahrendorf, W, Ramon, RL, Baker, M, Ramos-Lopez, F, Folegatti, PM, Quinkert, D, Ellis, KJ, Poulton, ID, Lawrie, AM, Cho, J-S, Nugent, FL, Spence, PJ, Silk, SE, Draper, SJ, Minassian, AM

Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-... by Satti, I, Marshall, JL, Harris, SA, Wittenberg, R, Tanner, R, Lopez Ramon, R, Wilkie, M, Ramos Lopez, F, Riste, M, Wright, D, Peralta Alvarez, MP, Williams, N, Morrison, H, Stylianou, E, Folegatti, P, Jenkin, D, Vermaak, S, Rask, L, Cabrera Puig, I, Powell Doherty, R, Lawrie, A, Moss, P, Hinks, T, Bettinson, H, McShane, H

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial by Datoo, MS, Dicko, A, Tinto, H, Ouédraogo, J-B, Hamaluba, M, Olotu, A, Beaumont, E, Ramos Lopez, F, Natama, HM, Weston, S, Chemba, M, Compaore, YD, Issiaka, D, Salou, D, Some, AM, Omenda, S, Lawrie, A, Bejon, P, Rao, H, Chandramohan, D, Roberts, R, Bharati, S, Stockdale, L, Gairola, S, Greenwood, BM, Ewer, KJ, Bradley, J, Kulkarni, PS, Shaligram, U, Hill, AVS

The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study by Schmit, N, Topazian, HM, Natama, HM, Bellamy, D, Traoré, O, Somé, MA, Rouamba, T, Tahita, MC, Bonko, MDA, Sourabié, A, Sorgho, H, Stockdale, L, Provstgaard-Morys, S, Aboagye, J, Woods, D, Rapi, K, Datoo, MS, Ramos Lopez, F, Charles, GD, McCain, K, Ouedraogo, J-B, Hamaluba, M, Olotu, A, Dicko, A, Tinto, H, Hill, AVS, Ewer, KJ, Ghani, AC, Winskill, P

Controlled human malaria infection with a clone of Plasmodium vivax with high quality genome assembly by Minassian, AM, Themistocleous, Y, Silk, SE, Barrett, JR, Kemp, A, Quinkert, D, Nielsen, CM, Edwards, NJ, Rawlinson, TA, Ramos Lopez, F, Roobsoong, W, Ellis, KJ, Cho, J-S, Aunin, E, Otto, TD, Reid, AJ, Bach, FA, Labbé, GM, Poulton, ID, Marini, A, Zaric, M, Mulatier, M, Lopez Ramon, R, Baker, M, Mitton, CH, Sousa, JC, Rachaphaew, N, Kumpitak, C, Maneechai, N, Suansomjit, C, Piteekan, T, Hou, MM, Khozoee, B, McHugh, K, Roberts, DJ, Lawrie, AM, Blagborough, AM, Nugent, FL, Taylor, IJ, Johnson, KJ, Spence, PJ, Sattabongkot, J, Biswas, S, Rayner, JC, Draper, SJ

Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination by Minassian, AM, Silk, SE, Barrett, JR, Nielsen, CM, Miura, K, Diouf, A, Loos, C, Fallon, JK, Michell, AR, White, MT, Edwards, NJ, Poulton, ID, Mitton, CH, Payne, RO, Marks, M, Maxwell-Scott, H, Querol-Rubiera, A, Bisnauthsing, K, Batra, R, Ogrina, T, Brendish, NJ, Themistocleous, Y, Rawlinson, TA, Ellis, KJ, Quinkert, D, Baker, M, Lopez Ramon, R, Ramos Lopez, F, Barfod, L, Folegatti, PM, Silman, D, Datoo, M, Taylor, IJ, Jin, J, Pulido, D, Douglas, AD, de Jongh, WA, Smith, R, Berrie, E, Noe, AR, Diggs, CL, Soisson, LA, Ashfield, R, Faust, SN, Goodman, AL, Lawrie, AM, Nugent, FL, Alter, G, Long, CA, Draper, SJ